[1] 庄心良,曾因明,陈伯銮主编.现代麻醉学[M].第3版,北京:人民卫生出版社,2003.1450-1. [2] Reves JG. Educational considerations for the clinical introduction and use of remifentanil [J]. Anesth Analg, 1999, 89(Suppl):S4-6. [3] Glass PS, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics ofremifentanil [J]. Anesth Analg, 1999, 89(Suppl):S7-14. [4] Glass PS, Shafer SL, Reves JG. Intravenous drug delivery system[A]. In:Miller RD. Anesthesia[M]. 5th ed., New York:Churchill Livingstone, 2001. 377-411. [5] Vuyk J, Mertens MJ, Olofsen E, et al. Propofol anesthesia and rational opioid selection [J]. Anesthesiology, 1997, 87 (12):1549-62. [6] Wilhelm W, Schlaich N, Harrer J, et al. Recovery and neurological examination after remifentanil-desflurane of fenanyl-desflurane anaesthesia for carolid artery surgery[J]. Br J Anaesth, 2001, 86(1):44-9. [7] Fleisher LA, Hogue S, Colopy M, et al. Does functional ability in the postoperative period differ between remifentanil-and fetanyl-based anesthesia[J]? J Clin Anesth, 2001, 13(6):401-6. [8] Mertens MJ, Olofsen E, Engbers FH, et al. Propofol reduces perioperative remifentanil requirements in a synergistic manner:response surface modeling of perioperative remifentanil-propofol interactions[J]. Anesthesiology, 2003, 99(8):347-59. |